{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:08Z","timestamp":1786979888925,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030052"],"award-info":[{"award-number":["82030052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00259-022-06088-x","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T02:02:48Z","timestamp":1672192968000},"page":"1665-1670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A prognostication system based on clinical parameters and [18F]-FDG PET\/CT in patients with newly diagnosed multiple myeloma"],"prefix":"10.1007","volume":"50","author":[{"given":"Junlong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-7399","authenticated-orcid":false,"given":"Xiaoli","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"6088_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.6004\/jnccn.2020.0057","volume":"18","author":"SK Kumar","year":"2020","unstructured":"Kumar SK, Callander NS, Adekola K, et al. Multiple myeloma, version 3.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18:1685\u2013717. https:\/\/doi.org\/10.6004\/jnccn.2020.0057.","journal-title":"J Natl Compr Canc Netw"},{"key":"6088_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/ejh.13006","volume":"100","author":"H Tu","year":"2018","unstructured":"Tu H, He Y, Huang T, et al. Predictive value of (18) F-FDG PET\/CT scanning in combination with clinical parameters in patients with newly diagnosed multiple myeloma. Eur J Haematol. 2018;100:189\u201397. https:\/\/doi.org\/10.1111\/ejh.13006.","journal-title":"Eur J Haematol"},{"key":"6088_CR3","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","volume":"109","author":"H Avet-Loiseau","year":"2007","unstructured":"Avet-Loiseau H, Avet-Loiseau H, Attal M, et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du My\u00e9lome. Blood. 2007;109:3489\u201395. https:\/\/doi.org\/10.1182\/blood-2006-08-040410.","journal-title":"Blood"},{"key":"6088_CR4","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1200\/JCO.21.02614","volume":"29","author":"M D\u2019Agostino","year":"2022","unstructured":"D\u2019Agostino M, Cairns DA, Lahuerta JJ, et al. Second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma: a European Myeloma Network (EMN) report within the HARMONY project. J Clin Oncol. 2022;29:3406\u201318. https:\/\/doi.org\/10.1200\/JCO.21.02614.","journal-title":"J Clin Oncol"},{"key":"6088_CR5","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538-548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"key":"6088_CR6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.bbmt.2015.03.001","volume":"21","author":"F Patriarca","year":"2015","unstructured":"Patriarca F, Carobolante F, Zamagni E, et al. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2015;21:1068\u201373. https:\/\/doi.org\/10.1016\/j.bbmt.2015.03.001.","journal-title":"Biol Blood Marrow Transplant"},{"key":"6088_CR7","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1182\/blood-2011-06-361386","volume":"118","author":"E Zamagni","year":"2011","unstructured":"Zamagni E, Patriarca F, Nanni C, et al. Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood. 2011;118:5989\u201395. https:\/\/doi.org\/10.1182\/blood-2011-06-361386.","journal-title":"Blood"},{"key":"6088_CR8","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/MNM.0000000000001242","volume":"41","author":"X Zhong","year":"2020","unstructured":"Zhong X, Diao W, Zhao C, et al. Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET\/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients. Nucl Med Commun. 2020;41:950\u20138. https:\/\/doi.org\/10.1097\/MNM.0000000000001242.","journal-title":"Nucl Med Commun"},{"key":"6088_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3348\/kjr.2018.19.3.481","volume":"19","author":"SH Moon","year":"2018","unstructured":"Moon SH, Choi WH, Yoo IR, et al. Prognostic value of baseline (18)F-fluorodeoxyglucose PET\/CT in patients with multiple myeloma: a multicenter cohort study. Korean J Radiol. 2018;19:481\u20138. https:\/\/doi.org\/10.3348\/kjr.2018.19.3.481.","journal-title":"Korean J Radiol"},{"key":"6088_CR10","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/s1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, et al. Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the international myeloma working group. Lancet Oncol. 2017;18:e206\u201317. https:\/\/doi.org\/10.1016\/s1470-2045(17)30189-4.","journal-title":"Lancet Oncol"},{"key":"6088_CR11","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s00259-018-3997-0","volume":"45","author":"A Stolzenburg","year":"2015","unstructured":"Stolzenburg A, L\u00fcckerath K, Samnick S, et al. Prognostic value of [(18)F]FDG-PET\/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation. Eur J Nucl Med Mol Imaging. 2015;45:1694\u2013704. https:\/\/doi.org\/10.1007\/s00259-018-3997-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6088_CR12","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3390\/cancers12092532","volume":"12","author":"AV Michaud-Robert","year":"2020","unstructured":"Michaud-Robert AV, Zamagni E, Carlier T, et al. Glucose metabolism quantified by SUVmax on baseline FDG-PET\/CT predicts survival in newly diagnosed multiple myeloma patients: combined harmonized analysis of two prospective phase III trials. Cancers. 2020;12:2532. https:\/\/doi.org\/10.3390\/cancers12092532.","journal-title":"Cancers"},{"key":"6088_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3324\/haematol.2013.094409","volume":"99","author":"L Pour","year":"2014","unstructured":"Pour L, Sevcikova S, Greslikova H, et al. Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse. Haematologica. 2014;99:360\u20134. https:\/\/doi.org\/10.3324\/haematol.2013.094409.","journal-title":"Haematologica"},{"key":"6088_CR14","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00277-020-04162-8","volume":"99","author":"J Du","year":"2020","unstructured":"Du J, Lu J, Gao W, et al. Serum-free light chains combined with the revised international staging system could further distinguish the superior and inferior clinical outcome of multiple myeloma patients. Ann Hematol. 2020;99:1779\u201391. https:\/\/doi.org\/10.1007\/s00277-020-04162-8.","journal-title":"Ann Hematol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-06088-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-022-06088-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-06088-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T10:32:53Z","timestamp":1681986773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-022-06088-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6088"],"URL":"https:\/\/doi.org\/10.1007\/s00259-022-06088-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"24 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}